Unicycive Therapeutics Inc

NASDAQ:UNCY   3:59:52 PM EDT
2.85
-0.06 (-2.06%)
Earnings Announcements

Unicycive Therapeutics Reports Q2 Loss Per Share Of $0.13

Published: 08/16/2021 10:36 GMT
Unicycive Therapeutics Inc (UNCY) - Unicycive Therapeutics Announces Second Quarter 2021 Financial Results.
Q2 Loss per Share $0.13.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.